Sulphafurazole Diethanolamine

Also known as: Sulfafurazole diethanolamine

Drug #2073

Sulphafurazol diethanolamine is a short acting sulphonamide i-e used similarly to sulfamethoxazole in urinary tract infections.

← Previous drug Next drug →

Primary Characteristics

Sulphafurazole Diethanolamine is also known as Sulfafurazole diethanolamine.

Molecular Weight: 372.4 · Non-proprietary name: Sulphafurazole diethanolamine.

Molecular structure of Sulphafurazole Diethanolamine

Pharmacokinetics

Distribution: Sulphafurazole Diethanolamine has a plasma protein binding is 85-90%.

Elimination: plasma half-life is 5-8hours, renal excretion is rapid.

Indications

Sulphafurazole Diethanolamine is primarily indicated in conditions like Pneumonia, Urinary tract infection.

Sulphafurazole Diethanolamine is also indicated for secondary conditions like Eye infections.

Contraindications

Sulphafurazole Diethanolamine is contraindicated in conditions like Hypersensitivity.

Dosage

Sulphafurazole Diethanolamine's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
3 g	3 g	—	oral
3 g	3 g	—	oral
3 g	3 g	—	oral	It should be followed by 4-8g per day in divided doses every 4-6 hours.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

2 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Sulphafurazole Diethanolamine in overdosage may give rise to further complications which include Aplastic anemia , Aplastic anemia , Epidermal necrolysis , Stevens johnson syndrome , Lupus erythematosus , Interstitial nephritis .

The signs and symptoms that are produced after acute overdosage of Sulphafurazole Diethanolamine are Exfoliative dermatitis , Fever, Pruritus .

Sulphafurazole Diethanolamine is known to cause more or less tolerable side effects which are usually transient. These include Anorexia , Ataxia, Diarrhea, Fatigue, Headache, Nausea and vomiting.

Warnings / Precautions

Adequate fluid intake is necessary to reduce risk of crystalluria. Treatment should be discontinued immediately if a rash appear. Complete blood count and urinalyses should be carried out during prolonged therapy.

Available Brands

None recorded.

Drug Classification

1.6.2.2.8 — Sulphonamides and trimethoprim